Dr. Jenna L. Wishnew, MD

Dr. Wishnew practices at Serge Lartchenko M.D. in Dallas, Texas.

Dr. Wishnew's NPI, 1932309283, was assigned on July 24, 2007. Dr. Wishnew graduated from UTMB Health in 2006. Dr. Wishnew's Texas license number on file is N8363.

Dr. Wishnew's primary practice is Serge Lartchenko M.D., at 2320 Hugo St, Dallas, TX 75204 in Dallas County. The practice phone is (214) 300-1364.

Dr. Wishnew's primary practice is Serge Lartchenko M.D. in Dallas, Texas. Dr. Wishnew is also affiliated with Methodist Richardson Medical Center. The medical group on file is Texas Infectious Disease Institute. Dmand AI also links Dr. Wishnew to 1 more hospital, 1 group practice or clinic, 1 home health agency and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wishnew practices, 4 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Wishnew's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Wishnew is board certified in surgery by the American Board of Surgery. Dr. Wishnew has a license on file in Texas.

Dmand AI lists abdominal adhesion surgery and removal of damaged skin or skin graft among the conditions Dr. Wishnew treats.

CMS data shows 2,007 Medicare services from Dr. Wishnew across 18 procedure codes in 2024, for 229 Medicare patients. Medicare paid $146,709 for them.

CMS counts 229 Medicare patients who saw Dr. Wishnew in 2024. The largest group is 75 to 84, with 93 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 22% are also on Medicaid. Their average risk score is 3.70, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Wishnew's median patient age at 69, with 52% women.

In 2024, Dr. Wishnew wrote 510 Medicare Part D claims for 97 patients. 82% of them were for generic drugs. CMS names the drug for 352 of them, across 12 drugs with 11 or more claims each, at $4,024 in total drug cost. In 2023, CMS named 386 claims across 11 drugs.

Dr. Wishnew accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 689 procedures of removal of tissue by Dr. Wishnew, more than 98% of the clinicians it reports for that procedure.

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 1 paper to Dr. Wishnew. Dr. Wishnew's most frequent co-author is Sharmila D. Dissanaike, MD.

CMS Open Payments shows 323 general payments to Dr. Wishnew from 53 drug and device companies from 2016 to 2025. Compensation for serving as faculty or as a speaker for a medical education program make up the largest share, 74% of the total. Kerecis Limited paid the most, $152,666.

Dmand AI lists 3 awards for Dr. Wishnew, most recently Women in Surgery Representative in 2019.

Dr. Wishnew graduated from UTMB Health in 2006. Dr. Wishnew is a member of ACS, Association of Women Surgeons and TMA.

Dr. Wishnew is in network with 21 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.